Researchers to collaborate on natural killer cell-based COVID-19 treatment

Green Cross LabCell, a South Korea-based biopharmaceutical company, announced it will begin development of a COVID-19 treatment based on its anticancer therapy work using natural killer cells. Human clinical trials for the treatment are expected to begin in the second half of this year in the U.S. and South […]

Click here to view original web page at

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.